Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Current Opinion in Endocrinology, Diabetes, and Obesity|February 9, 2024
APOC3 siRNA and ASO therapy for dyslipidemiaJasmine Chebli, Miriam Larouche, Daniel GaudetCurrent Atherosclerosis Reports|December 14, 2023
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe HypertriglyceridemiaMiriam Larouche, Etienne Khoury, Diane Brisson, et al.Journal of Clinical Lipidology|April 4, 2026
Lipoprotein lipase DNA methylation in the adipose tissue of patients with persistent chylomicronemiaMiriam Larouche, Diane Brisson, Catherine Laprise, et al.Current Opinion in Endocrinology, Diabetes, and Obesity|February 10, 2025
An overview of persistent chylomicronemia: much more than meets the eyeMiriam Larouche, Gerald F Watts, Christie Ballantyne, et al.Orphanet Journal of Rare Diseases|June 27, 2023
Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndromeMiriam Larouche, Diane Brisson, Marie-Claude Morissette, et al.Journal of Clinical Medicine|July 27, 2024
The Hurdle of Access to Emerging Therapies and Potential Solutions in the Management of DyslipidemiasBrett S Mansfield, Farzahna Mohamed, Miriam Larouche, et al.Clinical Biochemistry|February 13, 2023
Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activityDiane Brisson, Miriam Larouche, Jasmine Chebli, et al.Journal of the Endocrine Society|March 6, 2025
Treatment With Evinacumab Links a New Pathogenic Variant in the LPL Gene to Persistent ChylomicronemiaMiriam Larouche, Poulabi Banerjee, Diane Brisson, et al.Circulation Research|June 4, 2026
New and Emerging Therapeutic Targets for ApoB-Containing Particles LoweringDaniel Gaudet, Miriam Larouche, Frederick J Raal, et al.JCEM Case Reports|July 11, 2025
Glycerol Kinase Gene Variant as a Cause of Pseudohypertriglyceridemia and Apparent Poor Response to PlozasiranMiriam Larouche, Christie Ballantyne, Josiane Dufour, et al.Pageof 3